GlassScriptPhysician profile
Lenhanh Pham Tran
NPI 1801840376
$3,271.15
in general payments reported to CMS, 2019-2025
12 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $157 · 2021: $529 · 2022: $686 · 2023: $451 · 2024: $504 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,348 · Education: $17.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,347.78 |
| Education | $17.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $664.52 | 2019-2025 | Dupixent |
| Intersect Ent, INC. | $621.61 | 2019-2022 | |
| Cochlear Americas | $569.24 | 2019-2023 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Glaxosmithkline, LLC. | $527.98 | 2021-2025 | Nucala |
| Advanced Bionics, LLC | $162.44 | 2019-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Acclarent, INC | $161.43 | 2019-2022 | |
| Smith+Nephew, INC. | $156.02 | 2019-2021 | |
| Medtronic, INC. | $140.62 | 2022-2024 | Propel |
| Genzyme Corporation | $124.01 | 2024-2025 | |
| Kls-Martin L.P. | $70.74 | 2020-2022 | |
| Med-El Corporation | $42.04 | 2020-2021 | |
| Stryker Corporation | $30.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lenhanh Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.